Clinical Trial Update: Cisplatin + Etoposide +/- Concurrent ZD6474 in Previously Untreated Extensive Stage Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating cisplatin and etoposide with or without concurrent ZD6474 in previously untreated extensive-stage small cell lung cancer; tria…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Etoposide (Etoposide)
• ZD6474 (vandetanib)

Snippet

Sponsor: Hoosier Cancer Research Network | Conditions: Small Cell Lung Cancer | Phase 2 | Status: COMPLETED | Results posted: 2015-11-18